Almoosa Health Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,416	1,202	978.97	816.04	701.54
Revenue Growth (YoY)	17.79%	22.82%	19.97%	16.32%	11.54%
Cost of Revenue	993.19	834.02	674.5	587.73	486.9
Gross Profit	423.1	368.32	304.47	228.31	214.64
Selling, General & Admin	219.11	200.05	190.33	172.75	147.89
Other Operating Expenses	-22.49	-18.22	-13.82	-	-
Operating Expenses	203.46	186.23	180.44	172.75	147.89
Operating Income	219.64	182.09	124.03	55.56	66.75
Interest Expense	-18.15	-80.53	-22.59	-15.38	-3.82
Interest & Investment Income	8.64	-	-	-	-
Earnings From Equity Investments	0.54	1.19	-	-	-
Other Non Operating Income (Expenses)	29.84	-45.07	-	15.36	9.03
EBT Excluding Unusual Items	240.5	57.67	101.45	55.54	71.96
Gain (Loss) on Sale of Assets	0.22	0.11	0.33	0.03	-0.07
Asset Writedown	-	-	-	-0.01	-0.01
Pretax Income	240.72	57.78	101.78	55.56	71.88
Income Tax Expense	4.17	8.43	3.63	4.54	9.46
Net Income	236.54	49.35	98.15	51.02	62.42
Net Income to Common	236.54	49.35	98.15	51.02	62.42
Net Income Growth	379.28%	-49.71%	92.38%	-18.27%	-40.42%
Shares Outstanding (Basic)	44	35	35	35	0
Shares Outstanding (Diluted)	44	35	35	35	0
Shares Change (YoY)	26.15%	-	-	34900.00%	-
EPS (Basic)	5.36	1.41	2.80	1.46	624.20
EPS (Diluted)	5.36	1.41	2.80	1.46	624.20
EPS Growth	279.95%	-49.71%	92.38%	-99.77%	-
Free Cash Flow	-284.27	-56.66	-343.12	-318.15	-120.76
Free Cash Flow Per Share	-6.44	-1.62	-9.80	-9.09	-1207.55
Dividend Per Share	1.300	1.000	-	-	-
Dividend Growth	30.00%	-	-	-	-
Gross Margin	29.87%	30.63%	31.10%	27.98%	30.59%
Operating Margin	15.51%	15.14%	12.67%	6.81%	9.52%
Profit Margin	16.70%	4.11%	10.03%	6.25%	8.90%
Free Cash Flow Margin	-20.07%	-4.71%	-35.05%	-38.99%	-17.21%
EBITDA	305.01	257.04	182.72	105.45	88.99
EBITDA Margin	21.54%	21.38%	18.67%	12.92%	12.68%
D&A For EBITDA	85.37	74.95	58.69	49.89	22.24
EBIT	219.64	182.09	124.03	55.56	66.75
EBIT Margin	15.51%	15.14%	12.67%	6.81%	9.52%
Effective Tax Rate	1.73%	14.59%	3.57%	8.17%	13.16%
Advertising Expenses	24.51	19.17	8.96	10.58	7.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.